Induced pluripotent stem cells in long-QT syndrome

New England Journal of Medicine

Volumn 364, Issue 2, 2011, Pages 181-182

  Masuda, Shigeo ^a   Hanazono, Yutaka ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ASSAY; CELL DIFFERENTIATION; HEART MUSCLE CELL; HUMAN; LETTER; LONG QT SYNDROME; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

EID: 78651361546     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1012529     Document Type: Letter

References (5)

1. Moretti A, Bellin M, Welling A, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010;363:1397-409.
2. Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, Yamanaka S. Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 2009;4:200-1.
3. Ellis J, Bruneau BG, Keller G, et al. Alternative induced pluripotent stem cell characterization criteria for in vitro applications. Cell Stem Cell 2009;4:198-9.
4. Müller FJ, Goldmann J, Löser P, Loring JF. A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 2010;6:412-4.
5. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-86.